American Century Companies’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-27,651
Closed -$646K 2909
2024
Q2
$646K Buy
27,651
+8,540
+45% +$200K ﹤0.01% 2348
2024
Q1
$336K Buy
+19,111
New +$336K ﹤0.01% 2601